ImmuCell Corp. (ICCC)
10.25
-0.19
(-1.82%)
USD |
NASDAQ |
Oct 23, 16:00
10.25
0.00 (0.00%)
After-Hours: 20:00
ImmuCell Market Cap : 93.09M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 93.09M |
| October 22, 2026 | 94.82M |
| October 21, 2026 | 95.54M |
| October 20, 2026 | 94.91M |
| October 19, 2026 | 95.45M |
| October 16, 2026 | 97.63M |
| October 15, 2026 | 95.91M |
| October 14, 2026 | 97.63M |
| October 13, 2026 | 98.00M |
| October 12, 2026 | 87.19M |
| October 09, 2026 | 89.01M |
| October 08, 2026 | 88.55M |
| October 07, 2026 | 88.01M |
| October 06, 2026 | 90.55M |
| October 05, 2026 | 88.55M |
| October 02, 2026 | 88.55M |
| October 01, 2026 | 87.19M |
| September 30, 2026 | 89.01M |
| September 29, 2026 | 90.28M |
| September 28, 2026 | 89.73M |
| September 25, 2026 | 90.14M |
| September 24, 2026 | 90.55M |
| September 23, 2026 | 90.73M |
| September 22, 2026 | 90.73M |
| September 21, 2026 | 92.00M |
| Date | Value |
|---|---|
| September 18, 2026 | 90.37M |
| September 17, 2026 | 90.64M |
| September 16, 2026 | 87.28M |
| September 15, 2026 | 87.01M |
| September 14, 2026 | 88.19M |
| September 11, 2026 | 89.46M |
| September 10, 2026 | 90.05M |
| September 09, 2026 | 90.00M |
| September 08, 2026 | 89.37M |
| September 04, 2026 | 89.91M |
| September 03, 2026 | 90.82M |
| September 02, 2026 | 90.82M |
| September 01, 2026 | 90.10M |
| August 31, 2026 | 88.91M |
| August 28, 2026 | 90.28M |
| August 27, 2026 | 91.00M |
| August 26, 2026 | 91.00M |
| August 25, 2026 | 89.37M |
| August 24, 2026 | 89.37M |
| August 21, 2026 | 91.37M |
| August 20, 2026 | 91.64M |
| August 19, 2026 | 92.00M |
| August 18, 2026 | 88.64M |
| August 17, 2026 | 88.10M |
| August 14, 2026 | 91.28M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| PE Ratio | 122.32 |
| PS Ratio | 3.035 |
| Price to Book Value | 2.967 |
| Price to Free Cash Flow | 22.09 |
| Price | 10.25 |
| Earnings Yield | 0.82% |
| Operating PE Ratio | 49.88 |
| Normalized PE Ratio | 74.33 |